Patterns of plasma human immunodeficiency virus type 1 RNA response to antiretroviral therapy

The Journal of Infectious Diseases
W HuangJ Mellors

Abstract

Early identification of treatment failure among human immunodeficiency virus (HIV) type 1--infected patients receiving antiretroviral therapy could enable clinicians to modify inadequate regimens and to improve treatment response. Clinical definitions of treatment failure, however, may not be ideally suited for this purpose. This study empirically characterizes the patterns of HIV-1 RNA response to antiretroviral therapy in patients in 4 AIDS clinical trials. The approach assumed 2 patterns of HIV-1 response: "on track," for eventual suppression to HIV-1 RNA levels below the limit of quantification, and "off track," for deviation from this response. The results of this on- or off-track classification generally agreed with the protocol-defined outcomes of virologic success and failure, thus validating these commonly used definitions. Overall, only a minority of patients went off track because of suboptimal HIV-1 RNA response by the first follow-up visit. Most patients who went off track did so at later time points and had sharp unexpected rebounds without prior indication of a suboptimal response.

Citations

Aug 2, 2002·The Lancet Infectious Diseases·J X Velasco-HernandezS M Blower
Dec 6, 2002·The New England Journal of Medicine·Benjamin J Epstein
Feb 16, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Francois RaffiMiklos Salgo
Sep 10, 2011·AIDS Research and Human Retroviruses·Koen K A Van Rompay
Jul 28, 2011·The Journal of Infectious Diseases·Thomas C Quinn
Jan 1, 2008·The International Journal of Biostatistics·Jennifer SchumiVictor DeGruttola
Jun 24, 2014·Enfermedades infecciosas y microbiología clínica·UNKNOWN Panel de expertos de GeSIDA, UNKNOWN Plan Nacional sobre el Sida
Jul 16, 2004·The American Journal of the Medical Sciences·C Lynn Besch
Oct 29, 2013·Enfermedades infecciosas y microbiología clínica·UNKNOWN Panel de expertos de GeSIDA y Plan Nacional sobre el Sida
Jun 18, 2010·Enfermedades infecciosas y microbiología clínica·UNKNOWN Panel de Expertos de Gesida, UNKNOWN Plan Nacional sobre el Sida
Jul 23, 2009·Antiviral Research·Koen K A Van Rompay
Feb 26, 2004·Statistics in Medicine·Linsay GrayMarie-Louise Newell
Oct 31, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Barbara H McGovernRaymond T Chung
Jun 12, 2012·Biometrical Journal. Biometrische Zeitschrift·Dipankar BandyopadhyayDipak K Dey
May 12, 2015·Enfermedades infecciosas y microbiología clínica·UNKNOWN Panel de expertos de GeSIDA y Plan Nacional sobre el Sida
Jun 3, 2016·Annals of Clinical Microbiology and Antimicrobials·Kwamena William Coleman SagoeMax Arens
May 23, 2017·Lab Animal·Koen K A Van Rompay
Jun 28, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Hulin WuJohn G Gerber
Sep 5, 2001·Nature Medicine·S M BlowerJ O Kahn
Sep 10, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ana E SousaRui M M Victorino
Nov 19, 2003·Current Opinion in Infectious Diseases·Sunil Shaunak, Ian Teo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.